H. Einsele

1.8k total citations
35 papers, 893 citations indexed

About

H. Einsele is a scholar working on Oncology, Epidemiology and Hematology. According to data from OpenAlex, H. Einsele has authored 35 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Epidemiology and 12 papers in Hematology. Recurrent topics in H. Einsele's work include Multiple Myeloma Research and Treatments (9 papers), Antifungal resistance and susceptibility (5 papers) and Neutropenia and Cancer Infections (5 papers). H. Einsele is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Antifungal resistance and susceptibility (5 papers) and Neutropenia and Cancer Infections (5 papers). H. Einsele collaborates with scholars based in Germany, Switzerland and United States. H. Einsele's co-authors include Stefan Knop, Holger Hebart, Andreas K. Buck, Constantin Lapa, Samuel Samnick, Katharina Lückerath, Ken Herrmann, P Reusser, Olaf Penack and Georg Maschmeyer and has published in prestigious journals such as Blood, PLoS ONE and Annals of Oncology.

In The Last Decade

H. Einsele

34 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Einsele Germany 17 417 373 296 255 158 35 893
Caterina Giovanna Valentini Italy 19 372 0.9× 337 0.9× 292 1.0× 150 0.6× 155 1.0× 62 1.1k
Pietro Leoni Italy 17 345 0.8× 231 0.6× 290 1.0× 184 0.7× 162 1.0× 44 1.0k
Katsuya Fujimoto Japan 17 393 0.9× 274 0.7× 230 0.8× 179 0.7× 103 0.7× 58 1.2k
Clas F. R. Källander Sweden 19 326 0.8× 268 0.7× 145 0.5× 205 0.8× 208 1.3× 50 1.1k
Kathrin Rieger Germany 16 282 0.7× 227 0.6× 518 1.8× 215 0.8× 291 1.8× 32 1.4k
A Mazumder United States 12 307 0.7× 165 0.4× 276 0.9× 163 0.6× 137 0.9× 27 993
Karin Bilger France 21 339 0.8× 520 1.4× 873 2.9× 392 1.5× 134 0.8× 41 1.6k
Hilde Demuynck Belgium 11 153 0.4× 266 0.7× 217 0.7× 284 1.1× 121 0.8× 28 689
J. Simon Gronowitz Sweden 20 301 0.7× 257 0.7× 94 0.3× 240 0.9× 215 1.4× 46 1.1k
Guillemette Antoni France 17 158 0.4× 301 0.8× 120 0.4× 249 1.0× 97 0.6× 29 1.1k

Countries citing papers authored by H. Einsele

Since Specialization
Citations

This map shows the geographic impact of H. Einsele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Einsele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Einsele more than expected).

Fields of papers citing papers by H. Einsele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Einsele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Einsele. The network helps show where H. Einsele may publish in the future.

Co-authorship network of co-authors of H. Einsele

This figure shows the co-authorship network connecting the top 25 collaborators of H. Einsele. A scholar is included among the top collaborators of H. Einsele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Einsele. H. Einsele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duell, Johannes, Andreas Schirbel, Samuel Samnick, et al.. (2021). Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT. Journal of Nuclear Medicine. 62(10). 1415–1421. 43 indexed citations
2.
Cordonnier, Charlotte, Per Ljungman, Simone Cesaro, et al.. (2021). The EHA Research Roadmap: Infections in Hematology. HemaSphere. 5(12). e662–e662.
3.
Lapa, Constantin, Martin Schreder, Andreas Schirbel, et al.. (2016). [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values. Theranostics. 7(1). 205–212. 132 indexed citations
4.
Lückerath, Katharina, Constantin Lapa, Ken Herrmann, et al.. (2015). 11C-Methionine-PET: A novel and sensitive tool for monitoring of early response to treatment in multiple myeloma. Oncotarget. 6(10). 8418–8429. 32 indexed citations
5.
Lückerath, Katharina, Constantin Lapa, Gerhard Jörg, et al.. (2013). Targeting Paraprotein Biosynthesis for Non-Invasive Characterization of Myeloma Biology. PLoS ONE. 8(12). e84840–e84840. 24 indexed citations
6.
Kapp, Markus, Marc Schargus, Jan Springer, et al.. (2011). Endophthalmitis as primary clinical manifestation of fatal fusariosis in an allogeneic stem cell recipient. Transplant Infectious Disease. 13(4). 374–379. 13 indexed citations
7.
Staab, Adrian, Juergen Loeffler, Harun M. Said, et al.. (2011). Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro. Strahlentherapie und Onkologie. 187(4). 252–259. 27 indexed citations
8.
Leitner, Gerda, Simon Panzer, Hendrik W. Reesink, et al.. (2010). Preparation of granulocyte concentrates by apheresis. Vox Sanguinis. 98(4). 567–575. 6 indexed citations
9.
Kropff, Martin, Peter Liebisch, Stefan Knop, et al.. (2009). DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myeloma. Annals of Hematology. 88(11). 1125–1130. 33 indexed citations
11.
Einsele, H., et al.. (2008). Hochmalignes Non-Hodgkin-Lymphom bei Hyper-IgE-Syndrom. DMW - Deutsche Medizinische Wochenschrift. 115(30). 1141–1144. 1 indexed citations
12.
Böhme, Angelika, Markus Ruhnke, Dieter Buchheidt, et al.. (2008). Treatment of invasive fungal infections in cancer patients—Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Hematology. 88(2). 97–110. 90 indexed citations
13.
Pereira, Philippe L., Fritz Schick, H. Einsele, et al.. (2008). MR-Tomographie von Knochenmarkveränderungen nach Hochdosis-Chemotherapie und autologer peripherer Stammzeil-Transplantation. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 170(3). 251–257. 2 indexed citations
14.
Schmidt‐Hieber, Martin, Igor Wolfgang Blau, Rudolf Trenschel, et al.. (2007). Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma. Bone Marrow Transplantation. 39(7). 389–396. 31 indexed citations
15.
Einsele, H., Georg Rauser, Ulrich Grigoleit, et al.. (2002). Induction of CMV-specific T-cell lines using Ag-presenting cells pulsed with CMV protein or peptide. Cytotherapy. 4(1). 49–54. 25 indexed citations
16.
Beyer, J., Angelika Böhme, Dieter Buchheidt, et al.. (2000). Infektionsprophylaxe bei neutropenischen Patienten. DMW - Deutsche Medizinische Wochenschrift. 125(51/52). 1582–1588. 10 indexed citations
17.
Machann, J, et al.. (2000). MR-Charakterisierung der Zusammensetzung hämatopoetischen Knochenmarks. Der Radiologe. 40(8). 700–709. 4 indexed citations
18.
Hebart, Holger, C. Bokemeyer, Jürgen Löffler, et al.. (1997). New Aspects for the Diagnosis of Invasive Fungal Disease in Oncological Patients. Oncology Research and Treatment. 20(2). 99–104. 2 indexed citations
19.
Hebart, Holger, Christiane M. Erley, Markus König, et al.. (1996). Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinoma. Annals of Oncology. 7(4). 416–418. 20 indexed citations
20.
Hiddemann, Wolfgang, Georg Maschmeyer, Volker Runde, & H. Einsele. (1996). [Prevention, diagnosis and therapy of infections in patients with malignant diseases].. PubMed. 37(12). 1212–24. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026